Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 13, 2024

BUY
$23.07 - $32.77 $222,925 - $316,656
9,663 New
9,663 $271,000
Q4 2022

Feb 01, 2023

SELL
$25.29 - $35.48 $278,872 - $391,237
-11,027 Reduced 54.68%
9,141 $231,000
Q3 2022

Nov 10, 2022

SELL
$24.0 - $33.42 $102,600 - $142,870
-4,275 Reduced 17.49%
20,168 $594,000
Q2 2022

Aug 11, 2022

BUY
$24.78 - $33.36 $605,697 - $815,418
24,443 New
24,443 $667,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.